The Western Galilee Hospital in Nahariya Home Monitoring Registry
NCT ID: NCT01548755
Last Updated: 2012-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2012-04-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.
NCT05296954
Telemetric Arrhythmia Diagnosis in Adults
NCT01265758
Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy
NCT01265303
Change in Heart Rate Variability Prior to Tachyarrhythmia in ICD Implanted Patients
NCT00701467
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
NCT01557842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients implanted with the Lumax device family allows for a better automated follow up procedure via remote management (Home Monitoring).
The purpose of the registry is to assess workload of a Home Monitoring based follow up for Biotronik ICD and CRTD patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Implanted with or replaced with a Biotronik Lumax device.
* Patient is willing and able to sign consent form.
* Willing and able to attend clinic visits and follow up schedule.
* Transmission of more than 80% at 3-month FU.
* Patient older than 18 years.
Exclusion Criteria
* Life expectancy shorter than 12 months.
* Pregnancy.
* Participation in other clinical studies
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ron sela
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ron sela
Ron Sela, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Sela, MD
Role: PRINCIPAL_INVESTIGATOR
The Western Galilee Hospital in Nahariya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Western Galilee Hospital in Nahariya
Nahariya, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMR_Naharia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.